Participation on management and contribution to membership in ESFRI project ELIXIR - european infrastructure for integration of biological data
Public support
Provider
Ministry of Education, Youth and Sports
Programme
INGO II
Call for proposals
INGO II 3 (SMSM2013LG3)
Main participants
—
Contest type
VS - Public tender
Contract ID
MSMT-9344/2013-311
Alternative language
Project name in Czech
Účast na řízení a poplatky spojené s členstvím v ESFRI projektu ELIXIR - evropská infrastruktura pro integraci biologických dat.
Annotation in Czech
Cilem projektu je aktivní účast na řízení ELIXIR a koordinace činnosti s ostatními 12 evropskými státy při konstrukci infrastruktury. Ta by měla odpovídat požadavkům na dostupnost, komplexitu a standartizaci dat a umožnit vědeckým pracovištím tuto infrastrukturu využívat. Hlavními rysy budované infrastruktury je její interoperabilita a distribuce mezi uzly členských států ELIXIR.
Scientific branches
R&D category
IF - RDI infrastructure
CEP classification - main branch
EB - Genetics and molecular biology
CEP - secondary branch
EI - Biotechnology and bionics
CEP - another secondary branch
EE - Microbiology, virology
OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)
10603 - Genetics and heredity (medical genetics to be 3)<br>10604 - Reproductive biology (medical aspects to be 3)<br>10605 - Developmental biology<br>10606 - Microbiology<br>10607 - Virology<br>10608 - Biochemistry and molecular biology<br>10609 - Biochemical research methods<br>20801 - Environmental biotechnology<br>20802 - Bioremediation, diagnostic biotechnologies (DNA chips and biosensing devices) in environmental management<br>20803 - Environmental biotechnology related ethics<br>20901 - Industrial biotechnology<br>20902 - Bioprocessing technologies (industrial processes relying on biological agents to drive the process) biocatalysis, fermentation<br>20903 - Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials<br>30101 - Human genetics<br>30401 - Health-related biotechnology<br>30402 - Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)<br>30403 - Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions [pharmacogenomics, gene-based therapeutics])<br>30404 - Biomaterials (as related to medical implants, devices, sensors)<br>30405 - Medical biotechnology related ethics<br>40401 - Agricultural biotechnology and food biotechnology<br>40402 - GM technology (crops and livestock), livestock cloning, marker assisted selection, diagnostics (DNA chips and biosensing devices for the early/accurate detection of diseases) biomass feedstock production technologies, biopharming<br>40403 - Agricultural biotechnology related ethics
Completed project evaluation
Provider evaluation
U - Uspěl podle zadání (s publikovanými či patentovanými výsledky atd.)
Project results evaluation
ELIXIR Consortium Agreement ? ECA was signed in November 2013 by minister of the MYES and the Czech republic became one of the founders of the ELIXIR infrastructure which was one of the principal aids of the project. The ECA was signed by 6 countries ?UK, Switzerland, Sweden, Czech Republic, Estonia and Norway as well as international organiozation EMBL.
Solution timeline
Realization period - beginning
Mar 20, 2013
Realization period - end
Apr 8, 2014
Project status
U - Finished project
Latest support payment
Feb 25, 2014
Data delivery to CEP
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data delivery code
CEP15-MSM-LG-U/01:1
Data delivery date
Jul 2, 2015
Finance
Total approved costs
750 thou. CZK
Public financial support
750 thou. CZK
Other public sources
0 thou. CZK
Non public and foreign sources
0 thou. CZK